Abstract
Background Carbapenem-resistant Enterobacteriaceae have been recognized as an urgent antibiotic resistance threat for more than a decade. Despite this attention, their prevalence has remained steady or increased in some settings, suggesting that transmission pathways remain uncontrolled by current prevention strategies. We hypothesized that these transmission pathways, and hence targets for improved prevention, could be elucidated through comprehensive patient sampling, followed by integration of whole-genome sequencing (WGS) and epidemiological data.
Methods Longitudinal KPC+ Klebsiella pneumoniae (KPC-Kp) surveillance cultures were collected from 94% of patients in a long-term acute care hospital (LTACH) during a one-year bundled intervention to reduce KPC-Kp prevalence. WGS of 462 KPC-Kp isolates from 256 patients, and associated surveillance data were integrated using a distance threshold-free approach to identify transmission clusters that grouped patients acquiring KPC-Kp in the LTACH with the admission-positive ‘index’ patients that imported their strain into the facility. Plausible transmission pathways within clusters were identified using patient location data.
Findings Transmission clusters (N=49) had between 2-14 patients, capturing KPC-Kp acquisitions from 100 (80%) patients who first acquired KPC-Kp in the LTACH. Within-cluster genetic diversity varied from 0-154 (median 9) single-nucleotide variants (SNVs), with elevated diversity being driven by prolonged asymptomatic colonization and evolution of hypermutator strains. Transmission between patients in clusters could be explained by spatiotemporal overlap in patient rooms (14%), wards (66%), or facility (81%). Sequential exposure to the same patient room was the only epidemiological link for one patient, indicating that residual environmental contamination of rooms after patient discharge contributed little to transmission. Persistent, modifiable routes of transmission were associated with lapses in patient cohorting, transmission between cohort and non-cohort locations and clusters propagating due to false-negative surveillance.
Interpretation Integration of comprehensive surveillance and WGS data using a SNV threshold-free approach disclosed specific instances where improved patient and healthcare worker cohorting, reducing exposures to common locations outside of patient rooms, and improved KPC-Kp colonization detection could reduce transmission. Overall, results highlight the potential for WGS to monitor and improve infection prevention and the importance of combining rigorous sampling with appropriate analytical strategies to generate actionable hypotheses.
Funding CDC U54 CK000481, CDC U54 CK00016 04S2. S.E.H was supported by the University of Michigan NIH Training Program in Translational Research T32-GM113900 and the University of Michigan Rackham pre-doctoral fellowship.
Evidence before this study We searched PubMed for studies published before August 1, 2020, with no start date restriction, with the search terms KPC* OR carbapenem-resistant AND long-term acute care OR whole genome sequencing. We identified 16 reports that used whole genome sequencing and phylogenetic analysis to investigate nosocomial transmission of KPC-producing Klebsiella pneumoniae (KPC-Kp) in an endemic setting or during a prolonged outbreak (≥12 months.) Between 8 and 100 patients were included in each publication. Four studies used a single nucleotide variant (SNV) threshold (range, 16-80 SNVs) to define transmission clusters. Most studies did not seek environmental reservoirs of KPC-Kp, but 3 studies (2 by the same author) linked KPC-Kp transmission to contaminated sink drains in patient rooms.
Added value of this study We leveraged a large, comprehensive, longitudinal sample of KPC-Kp to demonstrate the value of whole genome sequencing using a SNV threshold-free approach in the investigation of transmission pathways within a long-term acute care hospital over one year. Patients in this endemic, high prevalence setting were colonized with genetically diverse strains that would have been misclassified epidemiologically if a strict SNV threshold were applied. We established that genomic diversity was driven by prolonged asymptomatic carriage of KPC-Kp and hypermutator strains. By integrating phylogenetic and spatiotemporal data, we discovered apparent failures in infection control processes that were associated with transmission of KPC-Kp, thereby identifying opportunities for process improvement. Sequential room exposure was rarely associated with transmission, indicating little role for residual environmental contamination in KPC-Kp transmission.
Implications of all the available evidence KPC-Kp continue to be a global public health challenge. Future analysis of comprehensive, carefully curated collections of isolates in different healthcare and community settings is needed to improve our understanding of genomic diversity within and between patients and elucidate underlying mechanisms. Integration of phylogenetic and traditional epidemiological methods is a powerful means of revealing nosocomial transmission pathways and opportunities for infection prevention.
Competing Interest Statement
Dr. Weinstein has participated in clinical studies where study hospitals or nursing homes received contributed product from Sage Products Inc., Molnlycke, Clorox, Medline, or Bio-K+. Neither Dr. Weinstein nor his hospital received product, funding, or payments.
Funding Statement
This work was supported by the CDC prevention Epicenters program underCDC U54 CK00016 04S2 and CDC U54 CK000481. Dr. Hawken received support from the University of Michigan NIH Trainig Program in Translational Research T32-GM113900 and the University of Michigan Rackham pre-doctoral fellowship.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The current study was reviewed and approved by the Rush University Medical Center institutional review board.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Upon acceptance into a peer reviewed journal, whole genome sequencing data will be available publicly under NCBI BioProject PRJNA603790.